Protease-Sensitive Synthetic Prions
Prions arise when the cellular prion protein (PrPC) undergoes a self-propagating conformational change; the resulting infectious conformer is designated PrPSc. Frequently, PrPSc is protease-resistant but protease-sensitive (s) prions have been isolated in humans and other animals. We report here that protease-sensitive, synthetic prions were generated in vitro during polymerization of recombinant (rec) PrP into amyloid fibers. In 22 independent experiments, recPrP amyloid preparations, but not recPrP monomers or oligomers, transmitted disease to transgenic mice (n = 164), denoted Tg9949 mice, that overexpress N-terminally truncated PrP. Tg9949 control mice (n = 174) did not spontaneously generate prions although they were prone to late-onset spontaneous neurological dysfunction. When synthetic prion isolates from infected Tg9949 mice were serially transmitted in the same line of mice, they exhibited sPrPSc and caused neurodegeneration. Interestingly, these protease-sensitive prions did not shorten the life span of Tg9949 mice despite causing extensive neurodegeneration. We inoculated three synthetic prion isolates into Tg4053 mice that overexpress full-length PrP; Tg4053 mice are not prone to developing spontaneous neurological dysfunction. The synthetic prion isolates caused disease in 600–750 days in Tg4053 mice, which exhibited sPrPSc. These novel synthetic prions demonstrate that conformational changes in wild-type PrP can produce mouse prions composed exclusively of sPrPSc.
Vyšlo v časopise:
Protease-Sensitive Synthetic Prions. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000736
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000736
Souhrn
Prions arise when the cellular prion protein (PrPC) undergoes a self-propagating conformational change; the resulting infectious conformer is designated PrPSc. Frequently, PrPSc is protease-resistant but protease-sensitive (s) prions have been isolated in humans and other animals. We report here that protease-sensitive, synthetic prions were generated in vitro during polymerization of recombinant (rec) PrP into amyloid fibers. In 22 independent experiments, recPrP amyloid preparations, but not recPrP monomers or oligomers, transmitted disease to transgenic mice (n = 164), denoted Tg9949 mice, that overexpress N-terminally truncated PrP. Tg9949 control mice (n = 174) did not spontaneously generate prions although they were prone to late-onset spontaneous neurological dysfunction. When synthetic prion isolates from infected Tg9949 mice were serially transmitted in the same line of mice, they exhibited sPrPSc and caused neurodegeneration. Interestingly, these protease-sensitive prions did not shorten the life span of Tg9949 mice despite causing extensive neurodegeneration. We inoculated three synthetic prion isolates into Tg4053 mice that overexpress full-length PrP; Tg4053 mice are not prone to developing spontaneous neurological dysfunction. The synthetic prion isolates caused disease in 600–750 days in Tg4053 mice, which exhibited sPrPSc. These novel synthetic prions demonstrate that conformational changes in wild-type PrP can produce mouse prions composed exclusively of sPrPSc.
Zdroje
1. PrusinerSB
1998 Prions. Proc Natl Acad Sci USA 95 13363 13383
2. OeschB
WestawayD
WälchliM
McKinleyMP
KentSBH
1985 A cellular gene encodes scrapie PrP 27–30 protein. Cell 40 735 746
3. PrusinerSB
1982 Novel proteinaceous infectious particles cause scrapie. Science 216 136 144
4. McKinleyMP
BoltonDC
PrusinerSB
1983 A protease-resistant protein is a structural component of the scrapie prion. Cell 35 57 62
5. MeyerRK
McKinleyMP
BowmanKA
BraunfeldMB
BarryRA
1986 Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83 2310 2314
6. BrownP
Coker-VannM
PomeroyK
FrankoM
AsherDM
1986 Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med 314 547 551
7. SafarJ
WilleH
ItriV
GrothD
SerbanH
1998 Eight prion strains have PrPSc molecules with different conformations. Nat Med 4 1157 1165
8. SafarJG
GeschwindMD
DeeringC
DidorenkoS
SattavatM
2005 Diagnosis of human prion disease. Proc Natl Acad Sci USA 102 3501 3506
9. GambettiP
DongZ
YuanJ
XiaoX
ZhengM
2008 A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63 697 708
10. HeadMW
KnightR
ZeidlerM
YullH
BarlowA
In press A case of protease sensitive prionopathy in a patient in the United Kingdom. Neuropathol Appl Neurobiol
11. HallDA
LeeheyMA
FilleyCM
SteinbartE
MontineT
2005 PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia. Neurology 64 1304 1306
12. BenestadSL
SarradinP
ThuB
SchonheitJ
TranulisMA
2003 Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec 153 202 208
13. OrgeL
GaloA
MachadoC
LimaC
OchoaC
2004 Identification of putative atypical scrapie in sheep in Portugal. J Gen Virol 85 3487 3491
14. KlingebornM
WikL
SimonssonM
RenstromLH
OttingerT
2006 Characterization of proteinase K-resistant N- and C-terminally truncated PrP in Nor98 atypical scrapie. J Gen Virol 87 1751 1760
15. HsiaoKK
ScottM
FosterD
GrothDF
DeArmondSJ
1990 Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250 1587 1590
16. TremblayP
BallHL
KanekoK
GrothD
HegdeRS
2004 Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 78 2088 2099
17. TellingGC
HagaT
TorchiaM
TremblayP
DeArmondSJ
1996 Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 10 1736 1750
18. InouyeH
BondJ
BaldwinMA
BallHL
PrusinerSB
2000 Structural changes in a hydrophobic domain of the prion protein induced by hydration and by Ala→Val and Pro→Leu substitutions. J Mol Biol 300 1283 1296
19. LawsDD
BitterH-ML
LiuK
BallHL
KanekoK
2001 Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc Natl Acad Sci USA 98 11686 11690
20. KanekoK
BallHL
WilleH
ZhangH
GrothD
2000 A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 295 997 1007
21. SupattaponeS
MuramotoT
LegnameG
MehlhornI
CohenFE
2001 Identification of two prion protein regions that modify scrapie incubation time. J Virol 75 1408 1413
22. LegnameG
BaskakovIV
NguyenH-OB
RiesnerD
CohenFE
2004 Synthetic mammalian prions. Science 305 673 676
23. LegnameG
NguyenH-OB
BaskakovIV
CohenFE
DeArmondSJ
2005 Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 102 2168 2173
24. LegnameG
NguyenH-OB
PeretzD
CohenFE
DeArmondSJ
2006 Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103 19105 19110
25. SafarJG
ScottM
MonaghanJ
DeeringC
DidorenkoS
2002 Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20 1147 1150
26. ColbyDW
ZhangQ
WangS
GrothD
LegnameG
2007 Prion detection by an amyloid seeding assay. Proc Natl Acad Sci USA 104 20914 20919
27. ColbyDW
GilesK
LegnameG
WilleH
BaskakovIV
2009 Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 106 20417 20422
28. CarlsonGA
EbelingC
YangS-L
TellingG
TorchiaM
1994 Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91 5690 5694
29. DeArmondSJ
IronsideJW
Bouzamondo-BernsteinE
PeretzD
FraserJR
2004 Neuropathology of prion diseases.
PrusinerSB
Prion Biology and Diseases. 2nd ed Cold Spring Harbor Cold Spring Harbor Laboratory Press 777 856
30. RogersDR
1965 Screening for amyloid with the thioflavin-t fluorescent method. Am J Clin Pathol 44 59 61
31. BaskakovIV
LegnameG
PrusinerSB
CohenFE
2001 Folding of prion protein to its native α-helical conformation is under kinetic control. J Biol Chem 276 19687 19690
32. BaskakovIV
LegnameG
BaldwinMA
PrusinerSB
CohenFE
2002 Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277 21140 21148
33. PastranaMA
SajnaniG
OniskoB
CastillaJ
MoralesR
2006 Isolation and characterization of a proteinase K-sensitive PrP(Sc) fraction. Biochemistry 45 15710 15717
34. WestawayD
DeArmondSJ
Cayetano-CanlasJ
GrothD
FosterD
1994 Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76 117 129
35. ShmerlingD
HegyiI
FischerM
BlattlerT
BrandnerS
1998 Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 203 214
36. MuramotoT
DeArmondSJ
ScottM
TellingGC
CohenFE
1997 Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix. Nat Med 3 750 755
37. CaugheyB
BaronGS
ChesebroB
JeffreyM
2009 Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78 177 204
38. ChesebroB
2003 Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66 1 20
39. CollingeJ
ClarkeAR
2007 A general model of prion strains and their pathogenicity. Science 318 930 936
40. MehlhornI
GrothD
StöckelJ
MoffatB
ReillyD
1996 High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35 5528 5537
41. ScottM
FosterD
MirendaC
SerbanD
CoufalF
1989 Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59 847 857
42. CarlsonGA
WestawayD
DeArmondSJ
Peterson-TorchiaM
PrusinerSB
1989 Primary structure of prion protein may modify scrapie isolate properties. Proc Natl Acad Sci USA 86 7475 7479
43. PeretzD
WilliamsonRA
KanekoK
VergaraJ
LeclercE
2001 Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 739 743
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen